About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 23 record(s)
Req # A-2020-18432
Copies of the daily calendar meetings, calls and other taskings for Mitchell Levine from June 1, 2019 to November 18, 2020.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18433
Copies of the daily calendar meetings, calls and other taskings for Melanie Bourassa-Forcier from June 1, 2019 to November 18, 2020.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18434
Copies of all completed Access to Information requests: A-2018-001, A-2018-002, A-2018-003, A-2018-004 and A-2019-0003.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18435
All briefing notes, memos, PowerPoints, policy briefs and reports submitted to the ISED Minister from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18442
A detailed summary of all occasions the PMPRB has used the excessive price penalty for pharmaceutical companies, broken down by date, company penalized, the name of the drug in question, the amount penalized, and a summary of why the price was excessive. Additionally, provide details of how much was collected under the penalty for the past five years and how the money gained from the penalties was used.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18732
A detailed summary of the PMPRB's use of the excessive price penalty on pharmaceutical companies from June 1, 2019 to November 26, 2020. For each penalty, break it down by date, company charged, drug in question, and fine levied.Organization: Patented Medicine Prices Review Board Canada
December 2020
Nothing to report this month
Organization: Jacques Cartier and Champlain Bridges Incorporated
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # 2340-600
As part of the Request for Proposals 62652 / Champlain Bridge, design-build services for the deconstruction of the original Champlain Bridge (2019-2023), an electronic copy of the following documents: •The Proposal – Financial Soundness and Technical Compliance Component of the Preferred Proponent; •The Proposal – Technical Qualitative Valuation Component of the Preferred Proponent; •The Proposal – Price Component of the Preferred Proponent; •Any document in JCCBI’s possession relating to the compliance of the Proposals received under the Request for Proposals; •All reports analyzing the conformity of Proposals, either internal or received from Consultants or externals firms ; •Any decision from JCCBI, the Evaluation Committee or any other person deciding for the purposes of the Procurement Process relating to the conformity of the Proposals as well as any document related to these decisions. •Any correspondence or exchange of information with the Preferred Proponent since the filing of Proposals.Organization: Jacques Cartier and Champlain Bridges Incorporated
September 2020